Clinical trial
High-Risk Breast Duct Epithelium
NCT00028340 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00028340 |
|---|---|
| Title | High-Risk Breast Duct Epithelium |
| Official title | Characterization of High-Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 156 |
| Start date | Feb 20, 2003 |
| Primary completion | Dec 16, 2022 |
| Completion | Dec 16, 2022 |
| First posted | Dec 24, 2001 |
| Last update posted | Jan 10, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: